Cytosorbents
CTSO
#10486
Rank
A$32.38 M
Marketcap
A$0.52
Share price
-2.54%
Change (1 day)
-66.17%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$32.54 Million, an increase over its 2023 earnings that were of -A$41.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-37.9%
2024 -A$32.54 Million-22.49%
2023 -A$41.98 Million-13.52%
2022 -A$48.55 Million34.04%
2021 -A$36.22 Million182.17%
2020 -A$12.84 Million-55.97%
2019 -A$29.15 Million14.17%
2018 -A$25.53 Million95.14%
2017 -A$13.09 Million-22.32%
2016 -A$16.85 Million39.1%
2015 -A$12.11 Million-12.89%
2014 -A$13.9 Million89%
2013 -A$7.36 Million26.65%
2012 -A$5.81 Million-26.02%
2011 -A$7.85 Million-288.45%
2010 A$4.16 M-4.17%
2009 A$4.34 M-287.19%
2008 -A$2.33 Million-47.12%
2007 -A$4.4 Million41.78%
2006 -A$3.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.35 B-29,618.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.11 B-6,233.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
A$79.46 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA